S H L Telemedicine Ltd

SW:SHLTN Switzerland Health Information Services
Market Cap
$43.71 Million
CHF40.02 Million CHF
Market Cap Rank
#29399 Global
#119 in Switzerland
Share Price
CHF1.08
Change (1 day)
+0.00%
52-Week Range
CHF0.74 - CHF2.36
All Time High
CHF20.00
Categories
Companies in Switzerland Health Information Services Technology
About

SHL Telemedicine Ltd., together with its subsidiaries, provides telemedicine services in Israel, Europe, and internationally. The company offers SmartHeart platform, a 12-lead electrocardiogram (ECG) that enables a full, hospital-quality ECG to be performed by a lay-person without the assistance of a healthcare professional. It also provides preventative healthcare, including annual medical check… Read more

S H L Telemedicine Ltd (SHLTN) - Net Assets

Latest net assets as of June 2025: CHF38.03 Million CHF

Based on the latest financial reports, S H L Telemedicine Ltd (SHLTN) has net assets worth CHF38.03 Million CHF as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF77.01 Million) and total liabilities (CHF38.98 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CHF38.03 Million
% of Total Assets 49.39%
Annual Growth Rate -3.8%
5-Year Change 3.62%
10-Year Change -7.86%
Growth Volatility 34.3

S H L Telemedicine Ltd - Net Assets Trend (2002–2024)

This chart illustrates how S H L Telemedicine Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for S H L Telemedicine Ltd (2002–2024)

The table below shows the annual net assets of S H L Telemedicine Ltd from 2002 to 2024.

Year Net Assets Change
2024-12-31 CHF39.25 Million -48.67%
2023-12-31 CHF76.46 Million +28.96%
2022-12-31 CHF59.29 Million -2.43%
2021-12-31 CHF60.76 Million +60.42%
2020-12-31 CHF37.88 Million +9.02%
2019-12-31 CHF34.74 Million -7.80%
2018-12-31 CHF37.68 Million +29.02%
2017-12-31 CHF29.21 Million +22.65%
2016-12-31 CHF23.82 Million -44.09%
2015-12-31 CHF42.60 Million -30.62%
2014-12-31 CHF61.40 Million -10.90%
2013-12-31 CHF68.91 Million +12.99%
2012-12-31 CHF60.99 Million -8.38%
2011-12-31 CHF66.56 Million -10.89%
2010-12-31 CHF74.70 Million +14.39%
2009-12-31 CHF65.30 Million +10.54%
2008-12-31 CHF59.07 Million -2.35%
2007-12-31 CHF60.50 Million +102.97%
2006-12-31 CHF29.81 Million -26.92%
2005-12-31 CHF40.78 Million -49.97%
2004-12-31 CHF81.52 Million -6.90%
2003-12-31 CHF87.56 Million -4.89%
2002-12-31 CHF92.06 Million --

Equity Component Analysis

This analysis shows how different components contribute to S H L Telemedicine Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 1123.1% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock CHF48.00K 0.12%
Other Comprehensive Income CHF-10.78 Million -27.46%
Other Components CHF158.20 Million 403.08%
Total Equity CHF39.25 Million 100.00%

S H L Telemedicine Ltd Competitors by Market Cap

The table below lists competitors of S H L Telemedicine Ltd ranked by their market capitalization.

Company Market Cap
Giga Metals Corporation
OTCQX:GIGGF
 		$8.18 Million
METALL ZUG N -B- (NDH1.SG)
STU:NDH1
 		$8.18 Million
Pioneerindo Gourmet International
JK:PTSP
 		$8.18 Million
Avantium N.V
PINK:AVTXF
 		$8.18 Million
Commerce Resources Corp
OTCQB:CMRZF
 		$8.18 Million
COSTCO WHSL - Dusseldorf Stock Exchang
DU:CTO
 		$8.18 Million
Tembaga Mulia Semanan Tbk
JK:TBMS
 		$8.18 Million
Ramsay Generale De Sante
PA:GDS
 		$8.18 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in S H L Telemedicine Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 73,528,000 to 39,248,000, a change of -34,280,000 (-46.6%).
  • Net loss of 28,095,000 reduced equity.
  • Other comprehensive income decreased equity by 6,541,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CHF-28.09 Million -71.58%
Other Comprehensive Income CHF-6.54 Million -16.67%
Other Changes CHF356.00K +0.91%
Total Change CHF- -46.62%

Book Value vs Market Value Analysis

This analysis compares S H L Telemedicine Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.45x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has increased from 0.13x to 0.45x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2002-12-31 CHF8.36 CHF1.08 x
2003-12-31 CHF8.00 CHF1.08 x
2004-12-31 CHF7.59 CHF1.08 x
2005-12-31 CHF3.71 CHF1.08 x
2006-12-31 CHF2.74 CHF1.08 x
2007-12-31 CHF5.59 CHF1.08 x
2008-12-31 CHF5.59 CHF1.08 x
2009-12-31 CHF6.17 CHF1.08 x
2010-12-31 CHF7.06 CHF1.08 x
2011-12-31 CHF6.33 CHF1.08 x
2012-12-31 CHF5.80 CHF1.08 x
2013-12-31 CHF6.59 CHF1.08 x
2014-12-31 CHF5.82 CHF1.08 x
2015-12-31 CHF4.06 CHF1.08 x
2016-12-31 CHF2.27 CHF1.08 x
2017-12-31 CHF2.78 CHF1.08 x
2018-12-31 CHF3.58 CHF1.08 x
2019-12-31 CHF3.31 CHF1.08 x
2020-12-31 CHF3.61 CHF1.08 x
2021-12-31 CHF4.05 CHF1.08 x
2022-12-31 CHF3.58 CHF1.08 x
2023-12-31 CHF4.51 CHF1.08 x
2024-12-31 CHF2.39 CHF1.08 x

Capital Efficiency Dashboard

This dashboard shows how efficiently S H L Telemedicine Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -71.58%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -49.48%
  • • Asset Turnover: 0.70x
  • • Equity Multiplier: 2.06x
  • Recent ROE (-71.58%) is below the historical average (-6.44%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2002 1.59% 1.57% 0.43x 2.34x CHF-7.47 Million
2003 -12.04% -10.32% 0.50x 2.32x CHF-18.67 Million
2004 -5.88% -4.58% 0.53x 2.44x CHF-12.74 Million
2005 -19.05% -7.62% 0.72x 3.47x CHF-11.51 Million
2006 -29.09% -13.47% 0.49x 4.41x CHF-11.37 Million
2007 38.70% 37.63% 0.43x 2.39x CHF17.33 Million
2008 3.78% 5.01% 0.54x 1.39x CHF-3.67 Million
2009 8.23% 11.23% 0.55x 1.33x CHF-1.15 Million
2010 6.51% 9.67% 0.53x 1.27x CHF-2.61 Million
2011 6.00% 9.43% 0.39x 1.63x CHF-2.66 Million
2012 -11.98% -27.11% 0.27x 1.64x CHF-13.40 Million
2013 3.24% 7.52% 0.27x 1.57x CHF-4.66 Million
2014 1.35% 2.07% 0.43x 1.50x CHF-5.31 Million
2015 -39.05% -48.10% 0.46x 1.75x CHF-20.89 Million
2016 -46.59% -27.37% 0.65x 2.63x CHF-13.48 Million
2017 8.24% 6.44% 0.57x 2.24x CHF-512.90K
2018 26.91% 20.75% 0.88x 1.47x CHF6.37 Million
2019 16.39% 13.60% 0.70x 1.72x CHF2.22 Million
2020 0.73% 0.69% 0.62x 1.71x CHF-3.51 Million
2021 -24.82% -28.46% 0.38x 2.28x CHF-19.80 Million
2022 -0.14% -0.13% 0.53x 1.99x CHF-5.64 Million
2023 -9.60% -12.36% 0.50x 1.54x CHF-14.41 Million
2024 -71.58% -49.48% 0.70x 2.06x CHF-32.02 Million

Industry Comparison

This section compares S H L Telemedicine Ltd's net assets metrics with peer companies in the Health Information Services industry.

No peer company data available for comparison.